tremelimumab,savolitinib,durvalumab
hutchmed,pfizer,astrazeneca,orpathys
['savolitinib', 'calypso', 'tremelimumab', 'renal,(-adrenal)', 'durvalumab']
calypso trial. a three-arm randomized phase ii study of durvalumab alone or with savolitinib or tremelimumab in previously treated advanced clear cell renal cancer #asco22 
Medical oncologist. Clinical researcher focused in GU tumors. Director Institute of Oncology. Associate Professor UCM. Hospital Clinico San Carlos Madrid, Spain